Stocks and Investing Stocks and Investing
Fri, August 28, 2020
Thu, August 27, 2020
Wed, August 26, 2020
Tue, August 25, 2020
Mon, August 24, 2020
Fri, August 21, 2020
Thu, August 20, 2020

Michelle Gilson Maintained (BMRN) at Strong Buy with Decreased Target to $95 on, Aug 20th, 2020


Published on 2024-10-27 12:24:40 - WOPRAI
  Print publication without navigation


Michelle Gilson of Canaccord Genuity, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Decreased Target from $119 to $95 on, Aug 20th, 2020.

Michelle has made no other calls on BMRN in the last 4 months.



There are 4 other peers that have a rating on BMRN. Out of the 4 peers that are also analyzing BMRN, 3 agree with Michelle's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Paul Matteis of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $100 on, Wednesday, August 19th, 2020
  • George Farmer of "BMO Capital" Maintained at Hold with Increased Target to $108 on, Thursday, August 6th, 2020
  • Matthew Harrison of "Morgan Stanley" Downgraded from Buy to Hold and Held Target at $125 on, Wednesday, July 8th, 2020


This is the rating of the analyst that currently disagrees with Michelle


  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $113 on, Wednesday, August 19th, 2020